E Calonje Selected Research

E Calonje Research Topics

Disease

3	Melanoma (Melanoma, Malignant) 01/2019 - 05/2002
3	Neoplasms (Cancer) 07/2002 - 06/2001
3	B-Cell Lymphoma (Lymphoma, B Cell) 10/2001 - 04/2001
2	Basal Cell Carcinoma (Rodent Ulcer) 08/2019 - 07/2007
1	COVID-19 02/2022
1	Sickle Cell Trait 02/2022
1	Anorexia 02/2022
1	Insect Bites and Stings (Insect Bite) 12/2021
1	Chilblains (Chilblain) 10/2019
1	Airway Obstruction (Choking) 01/2018
1	Merkel Cell Carcinoma 01/2016
1	Fibroma (Fibromatosis) 10/2010
1	Histiocytosis 04/2008
1	Neurofibrosarcoma (MPNST) 02/2008
1	Plexiform Neurofibroma 02/2008
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 02/2008
1	Hypoxia (Hypoxemia) 01/2007
1	Pathologic Constriction (Stenosis) 01/2007
1	Hepatitis C 05/2006
1	Chronic Hepatitis C 05/2006
1	Sarcoidosis (Schaumann Disease) 05/2006
1	Granuloma 01/2006
1	Darier Disease (Darier's Disease) 09/2003
1	Purpura 09/2003
1	Urticaria (Hives) 09/2003
1	Kidney Neoplasms (Kidney Cancer) 06/2003
1	Leiomyomatosis 06/2003
1	Hereditary leiomyomatosis and renal cell cancer 06/2003
1	Contact Dermatitis (Eczema, Contact) 05/2003
1	Extranodal NK-T-Cell Lymphoma 03/2003
1	Lymphoma (Lymphomas) 03/2003
1	Neoplasm Metastasis (Metastasis) 07/2002
1	Glomus Tumor (Glomus Tumors) 03/2002
1	Hypopigmentation (Hypomelanosis) 11/2001
1	Tuberous Sclerosis (Bourneville's Disease) 11/2001
1	Angiofibroma 11/2001
1	Cicatrix (Scar) 11/2001
1	Erythema 03/2001
1	Fibrosis (Cirrhosis) 03/2001
1	Disease Progression 12/2000
1	Verrucous Carcinoma 07/2000
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 05/2000
1	Necrosis 05/2000
1	Epilepsy (Aura) 05/2000
1	Reactive angioendotheliomatosis 05/2000
1	Coma (Comas) 05/2000

Drug/Important Bio-Agent (IBA)

3	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 10/2001 - 04/2001
2	S100 Proteins (S 100 Protein)IBA 07/2002 - 05/2002
1	tetracarboxyphenylporphineIBA 02/2022
1	Agammaglobulinaemia Tyrosine KinaseIBA 12/2021
1	ibrutinibIBA 12/2021
1	Imiquimod (Aldara)FDA LinkGeneric 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Syntex adjuvant formulationIBA 10/2010
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2008
1	Mucin-1 (CA 15-3 Antigen)IBA 07/2007
1	Immunoglobulin G (IgG)IBA 01/2007
1	Melanins (Melanin)IBA 05/2006
1	Interferon-alpha (Interferon Alfa)IBA 05/2006
1	Ribavirin (Virazole)FDA LinkGeneric 05/2006
1	AluminumIBA 01/2006
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 09/2003
1	CollagenIBA 09/2003
1	Immunoglobulins (Immunoglobulin)IBA 09/2003
1	RetinoidsIBA 09/2003
1	Fumarate Hydratase (Fumarase)IBA 06/2003
1	Fumaric aciduriaIBA 06/2003
1	Phenol (Carbolic Acid)FDA Link 05/2003
1	Messenger RNA (mRNA)IBA 03/2003
1	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 03/2003
1	Phosphopyruvate Hydratase (Enolase)IBA 07/2002
1	DesminIBA 07/2002
1	VimentinIBA 07/2002
1	ParaffinIBA 07/2002
1	MyogeninIBA 07/2002
1	Colloids (Colloid)IBA 05/2002
1	Coloring Agents (Dyes)IBA 05/2002
1	Calcium-Binding ProteinsIBA 05/2002
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 03/2002
1	EnzymesIBA 03/2002
1	ImmunosorbentsIBA 03/2002
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2002
1	Carbon DioxideIBA 11/2001
1	Phenobarbital (Luminal)FDA Link 06/2001
1	polyacrylamideIBA 04/2001
1	DNA (Deoxyribonucleic Acid)IBA 07/2000
1	Factor VIII (Coagulation Factor VIII)IBA 05/2000
1	Warfarin (Coumadin)FDA LinkGeneric 05/2000

Therapy/Procedure

5	Therapeutics 04/2008 - 05/2000
2	Drug Therapy (Chemotherapy) 03/2003 - 04/2000
2	Lasers (Laser) 11/2001 - 03/2001
1	Free Tissue Flaps 10/2019
1	Mohs Surgery (Mohs' Micrographic Surgery) 08/2019
1	Laser Therapy (Surgery, Laser) 01/2018
1	Tattooing 05/2006
1	Aftercare (After-Treatment) 09/2003
1	Photochemotherapy (Photodynamic Therapy) 09/2003
1	Surgical Amputation (Amputations) 07/2002
1	Radiotherapy 07/2002
1	Gas Lasers 11/2001